Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 66.80
+1.20 (1.83%)
Jul 24, 2026, 5:29 PM CET
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 883.73 million as of July 24, 2026. Its market cap has increased by 30.94% in one year.
Market Cap
883.73M
Enterprise Value
751.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
66.80
ChartMarket Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 883.73M, an increase of 371.34%. That is a compound annual growth rate of 16.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 883.73M | 29.90% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.82B |
| BioInvent International AB | 1.51B |
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 1.08B |
| SynAct Pharma AB | 1.02B |
| AlzeCure Pharma AB | 910.12M |
| Xspray Pharma AB | 715.99M |
| Oncopeptides AB | 648.27M |